Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update Re Issue of Equity

28 May 2020 15:16

RNS Number : 2655O
Pathfinder Minerals Plc
28 May 2020
 

28 May 2020

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Update Re Issue of Equity

 

Further to the Issue of Equity announcement released by the Company on 11 May 2020, Pathfinder has agreed, following discussions with its broker, to amend the terms of the placing and subscription to align pricing closer to the Company's current share price.

In aggregate, the same quantum of gross proceeds of £250,000 is still to be raised via a placing and subscription, which will now be for 38,461,538 new ordinary shares of 0.1p each in the Company ("Ordinary Shares"), reflecting an issue price of 0.65p per share (the "Fundraise"), being equal to the closing mid-market share price of the Company on 27 May 2020.

 

As previously announced, the net proceeds will provide the Company with additional working capital to pursue the recovery of an interest in Mining Concession 4623C, as well as for general working capital purposes. When added to the expected cash inflow from the convertible loan note instrument announced on 3 April 2020, the Board believes the Company should have sufficient funds on its current cost basis to continue operations into 2021.

 

Annual Broker Fees

 

As previously announced, the Company has appointed Novum Securities Limited ("Novum") as its broker. The Company has agreed with Novum to settle its annual broking fee in advance through the issuance of 3,076,923 new Ordinary Shares to Novum (the "Fee Shares").

 

Admission to trading on AIM

 

The Company will apply for the admission of the 38,461,538 new Ordinary Shares to be issued pursuant to the Fundraise (the "Fundraise Shares") and the 3,076,923 Fee Shares to trading on AIM and this is expected to take place on or around 3 June 2020 ("Admission"). 

 

Following Admission, the Company's issued share capital will consist of 360,223,831 Ordinary Shares with no Ordinary Shares held in treasury. Therefore, the above figure of 360,223,831 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Pathfinder under the FCA's Disclosure and Transparency Rules.

 

Richard Jennings, who, together with his related parties, Align Research and C. A. Jennings, currently holds a total of 9.1 percent of the Company's issued share capital, has committed to subscribe for 3,076,923 Fundraise Shares on the revised terms. Following Admission of the Fundraise Shares and the Fee Shares, Align Research and related parties - R. S. and C. A. Jennings, will have an enlarged shareholding of 32,076,923 Ordinary Shares, representing 8.9 percent of the then enlarged issued share capital of the Company. 

 

Issue of Warrants

 

Pursuant to the Fundraise, the Company has also issued to the recipients of the Fundraise Shares warrants to subscribe for one new Ordinary Share for every one Fundraise Share subscribed for, with an exercise price of 1.5p (the "Warrants"), 50 percent of which are proposed to be allotted and issued by the Company pursuant to the Fundraise by Admission, and 50 percent to be issued conditional upon the passing of the necessary resolutions by shareholders at the next General Meeting of the Company authorising their allotment (the "GM Approval"), exercisable for a period of two years from the date of the admission to trading on AIM of the Fundraise Shares.

 

In connection with the Fundraise, the Company has agreed to issue Novum warrants over 3,230,769 Ordinary Shares (previously 1,800,000 Ordinary Shares) on the same terms as above (the "Novum Warrants"). Warrants over a further 153,846 Ordinary Shares (previously 200,000 Ordinary Shares) will be issued to another corporate adviser in relation to the Fundraise (the "Other Adviser Warrants"). The issuance of the Novum Warrants and the Other Adviser Warrants will also be subject to GM Approval.

 

 

Dennis Edmonds, Chief Executive Officer of Pathfinder, commented:

 

"We are encouraged that all of the investors have maintained their commitment to the Fundraise, rebased to yesterday's closing share price. We continue to work towards a commercial resolution to the licence dispute."

 

Enquiries:

Pathfinder Minerals Plc

Dennis Edmonds, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

Novum Securities Limited (Corporate Broker)

Colin Rowbury / Jon Belliss

Tel. +44 (0)20 7399 9400

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFLSEEITFII
Date   Source Headline
27th Feb 20247:00 amRNSUpdate on Rome Resources
29th Jan 202410:21 amRNSAmendment to the revised IM Minerals SPA
2nd Jan 202410:00 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
22nd Dec 20239:56 amRNSSubscription to raise £1.275 million and TVR
21st Dec 20235:05 pmRNSResult of General Meeting
4th Dec 20237:00 amRNSNotice of GM
29th Nov 20237:30 amRNSSuspension - Pathfinder Minerals PLC
29th Nov 20237:00 amRNSProposed Acquisition, Subscription & Suspension
3rd Nov 202312:56 pmRNSHolding in Company
26th Sep 20237:00 amRNSHalf-Year Results
1st Sep 20237:00 amRNSProposed Bonus Shares Timetable
18th Aug 20231:42 pmRNSResult of GM & Completion of Disposal
16th Aug 20237:00 amRNSBoard Changes & Proposed Issue of Bonus Shares
31st Jul 20237:00 amRNSNotice of GM
28th Jul 20234:14 pmRNSEntry into revised SPA for sale of IM Minerals
26th Jul 20237:00 amRNSChange of Nominated Adviser and Broker
4th Jul 20234:07 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSResult of AGM and Board Changes
19th Jun 20235:04 pmRNSHolding(s) in Company
14th Jun 20234:27 pmRNSUpdate re Sale of IM Minerals
30th May 20233:14 pmRNSUpdate re Sale of IM Minerals
25th May 20237:01 amRNSNotice of AGM
25th May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSUpdate re Sale of IM Minerals
11th May 20235:00 pmRNSUpdate re Sale of IM Minerals: Result of Meeting
28th Apr 20237:25 amRNSAmendment to Share Option Terms
21st Apr 20237:00 amRNSRevised SPA, Posting of Circular and Notice of GM
12th Apr 20237:00 amRNSUpdate re Sale of IM Minerals
22nd Mar 20232:05 pmRNSSecond Price Monitoring Extn
22nd Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSSPA Signed for Sale of IM Minerals
22nd Feb 20237:00 amRNSUpdate re Sale of IM Minerals
2nd Feb 202311:14 amRNSHolding(s) in Company
1st Feb 20237:01 amRNSUpdate re Bilateral Investment Treaty Claim
1st Feb 20237:00 amRNSPlacing Completion and Total Voting Rights
27th Jan 20235:12 pmRNSResult of General Meeting
9th Jan 20237:00 amRNSNotice of GM
4th Jan 20237:00 amRNSUpdate re Bilateral Investment Treaty Claim
3rd Jan 20237:00 amRNSConditional Placing to Raise £0.5 Million
28th Dec 20223:44 pmRNSUpdate re Loan Agreement
8th Nov 20225:26 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
29th Sep 20227:02 amRNSLoan Agreement
29th Sep 20227:00 amRNSUpdate re Bilateral Investment Treaty Claim
30th Jun 20224:14 pmRNSResult of Annual General Meeting
17th Jun 20224:58 pmRNSNotice of AGM Explanatory Notes
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.